Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$331.3K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
2 of 9 filings we hold were filed after the two-business-day deadline. The furthest past the deadline was 15 business days late.
The 10 most recent Form 4 transactions.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
| Jul 16 | QTTB | Q32 Bio Inc. | AGRANT | 132,000 | — | — | +59.7% | Open the original filing on SEC.gov |
| Feb 25 | QTTB | Q32 Bio Inc. | SSELL | 9,896 | $4.51 | $44.7K | -10.0% | Open the original filing on SEC.gov |
| Feb 24 | QTTB | Q32 Bio Inc. | AGRANT | 132,000 | — | — | +148.1% | Open the original filing on SEC.gov |
| Dec 2, 2025 | QTTB | Q32 Bio Inc. | SSELL | 22,506 | $3.46 | $77.9K | -18.5% | Open the original filing on SEC.gov |
| Aug 26, 2025 | QTTB | Q32 Bio Inc. | SSELL | 10,494 | $1.80 | $18.9K | -8.0% | Open the original filing on SEC.gov |
| Jul 25, 2025 | VERV | Verve Therapeutics, Inc. | DTOISS◆ | 42,200 | — | — | — | Open the original filing on SEC.gov |
| Jul 25, 2025 | VERV | Verve Therapeutics, Inc. | DTOISS◆ | 267,541 | — | — | — | Open the original filing on SEC.gov |
| Jun 5, 2025 | VERV | Verve Therapeutics, Inc. | AGRANT◆ | 42,200 | — | — | — | Open the original filing on SEC.gov |